Sanofi SA (SASY)

Xetra


Symbol		Exchange		Currency
SASY	·	Paris	·	EUR	Real-time
SANp	·	BATS Europe	·	EUR	Delayed
SNY	·	NASDAQ	·	USD	Real-time
0O59	·	London	·	EUR	Real-time
SNYN	·	Mexico	·	MXN	Delayed
SANF	·	Milan	·	EUR	Real-time
SASY	·	TradeGate	·	EUR	Delayed
SNYy	·	TradeGate	·	EUR	Delayed
SASY	·	Xetra	·	EUR	Delayed
SASY	·	Frankfurt	·	EUR	Delayed
SASY	·	Vienna	·	EUR	Real-time

Currency in EUR

92.120

-1.310(-1.40%)

Closed·23/05

Fair Value

Unlock Value

Day's Range

91.150

93.560

52 wk Range

86.000

110.820

Sanofi (SASY) Income Statement & Profits

Assess the Sanofi Income Statement (earnings report), showing the company's financial performance from operating and non operating activities such as revenue, expenses and income. Check assets and liabilities, diluted earnings per share (EPS), and net income after taxes for the last 4 periods (either quarterly or annually).

Investors who need greater depth or who want to customise how data is presented to fit their own investment styles are able to do so via their very own InvestingPro account.

Advanced Income Statement

Period Ending:

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

Total Revenues

aa.aa

37,369

39,175

40,304

41,109

44,286

Total Revenues Growth

aa.aa

-0.7%

+4.83%

+2.88%

+2%

+7.73%

Cost Of Revenues

aa.aa

12,106

12,251

11,869

12,619

13,195

Gross Profit

aa.aa

25,263

26,924

28,435

28,490

31,091

Gross Profit Growth

aa.aa

-1.53%

+6.57%

+5.61%

+0.19%

+9.13%

Gross Profit Margin %

aa.aa

67.6%

68.73%

70.55%

69.3%

70.21%

Other Operating Expenses, Total

aa.aa

17,684

18,359

18,054

20,369

22,222

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-6.2%	+3.82%	-1.66%	+12.82%	+9.1%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	5,530	5,692	6,501	6,507	7,394
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	9,448	9,599	8,785	9,003	9,247
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	1,025	1,488	1,190	2,948	3,832

Operating Income

aa.aa

7,579

8,565

10,381

8,121

8,869

Operating Income Growth

aa.aa

+11.42%

+13.01%

+21.2%

-21.77%

+9.21%

EBIT Margin %

aa.aa

20.28%

21.86%

25.76%

19.75%

20.03%

Net Interest Expenses

aa.aa

-422

-359

-163

-62

-228

Net Interest Expenses Growth

aa.aa

+6.84%

+14.93%

+54.6%

+61.96%

-267.74%

Interest Expense, Total

aa.aa

-459

-362

-402

-589

-641

Interest And Investment Income

aa.aa

239

527

413

Other Non Operating Expenses, Total

aa.aa

497

111

-712

-202

EBT, Excl. Unusual Items

aa.aa

7,654

8,317

10,256

7,347

8,439

Gain (Loss) On Sale Of Assets

aa.aa

443

418

481

484

539

Other Unusual Items, Total

aa.aa

-206

-77

344

-676

-814

EBT, Incl. Unusual Items

aa.aa

14,137

7,837

9,992

6,115

6,758

EBT, Incl. Unusual Items Growth

aa.aa

+370.14%

-44.56%

+27.5%

-38.8%

+10.52%

EBT, Incl. Unusual Items Margin

aa.aa

37.83%

20.01%

24.79%

14.88%

15.26%

Income Tax Expense

aa.aa

1,807

1,558

1,909

1,017

1,204

Net Income to Company

aa.aa

12,330

6,279

8,484

5,436

5,618

Minority Interest

aa.aa

-36

-56

-113

-36

-58

Net Income

aa.aa

12,294

6,223

8,371

5,400

5,560

Net Income Growth

aa.aa

+346.41%

-49.38%

+34.52%

-35.49%

+2.96%

Net Income Margin %

aa.aa

32.9%

15.89%

20.77%

13.14%

12.55%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

12,294

6,223

7,970

5,062

5,496

Basic EPS - Continuing Operations

aa.aa

9.81

4.97

6.37

4.04

4.39

Basic EPS - Continuing Operations Growth

aa.aa

+329.34%

-49.34%

+28.13%

-36.48%

+8.6%

Diluted EPS - Continuing Operations

aa.aa

9.76

4.95

6.35

4.04

4.39

Diluted EPS - Continuing Operations Growth

aa.aa

+329.96%

-49.28%

+28.28%

-36.31%

+8.55%

Basic Weighted Average Shares Outstanding

aa.aa

1,253.6

1,252.5

1,251.9

1,251.7

1,251.4

Diluted Weighted Average Shares Outstanding

aa.aa

1,260.1

1,257.9

1,256.9

1,256.4

1,256.1

Dividend Per Share

aa.aa

3.2

3.33

3.56

3.76

3.92

Dividend Per Share Growth

aa.aa

+1.59%

+4.06%

+6.91%

+5.62%

+4.26%

EBITDA

aa.aa

10,466

11,251

13,093

11,076

11,664

EBITDA Growth

aa.aa

+3.49%

+7.5%

+16.37%

-15.41%

+5.31%

EBITDA Margin %

aa.aa

28.01%

28.72%

32.49%

26.94%

26.34%

EBIT

aa.aa

7,579

8,565

10,381

8,121

8,869

* In Millions of EUR (except for per share items)

FTSE 100

8,717.97

-21.29

-0.24%

DAX

23,629.58

-369.59

-1.54%

Euro Stoxx 50

5,328.65

-95.83

-1.77%

S&P 500

5,802.83

-39.18

-0.67%

Nikkei 225

37,160.47

+174.60

+0.47%

Dow Jones

41,603.07

-256.02

-0.61%

FTSE 100 Futures

8,739.80

-28.3

-0.32%

Market Movers

Name	Last	Chg. %	Vol.
BP	356.20	-0.17%	68.76M
HSBC	868.80	-1.34%	26.11M
Anglo American	2,191.5	+3.37%	13.39M
Shell	2,420.0	-0.82%	12.14M
British American Tobacco	3,335.0	+1.24%	8.50M
Reckitt Benckiser	4,929.0	+0.39%	4.71M
AstraZeneca	10,436.0	+0.60%	3.09M

Name	Last	Chg. %	Vol.
Inteliqo	0.03	+400.99%	0.00
Iconic Labs	3.5000	+89.19%	11.89M
Medincell	16.30	+86.29%	0.00
Defence Holdings	0.50	+72.41%	138.99M
Mast Energy Developments	0.51	+46.24%	82.13M
Gowin New Energy	0.0001	+33.33%	0.00
Chesterfield Resources	0.73	+30.91%	6.24M

Name	Last	Chg. %	Vol.
Tectonic Gold	0.002	-94.29%	0.00
Totally	0.30	-79.30%	30.14M
Semperit AG Holding	13.60	-41.38%	0.00
ChallengerX plc	0.25	-37.50%	400.00K
Carlo Gavazzi Holding AG	218.00	-33.54%	0.00
Schweizerische Nationalbank	3,170.00	-30.48%	1.00
Phaxiam Therapeutics	0.21	-27.78%	24.07K

Trending Stocks

Name	Last	Chg. %	Vol.
Rolls-Royce Holdings	835.80	-0.38%	26.92M
Greatland Gold	13.600	+3.03%	57.13M
IAG	319.80	-2.02%	32.62M
Marks & Spencer	375.20	-2.29%	9.58M
Defence Holdings	0.50	+72.41%	138.99M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaaaaa A A	1,425.50	+44.37%	2,057.99
Aaaaaaaa Aaaaaaaaaa	356.20	+38.05%	491.73
Aaaaaaaaaaaaaaaa	10,436.0	+25.20%	13,065.87
A Aa Aa Aaaaaaa	158.60	+24.21%	197.00
Aaaaaaaa	4,562.5	+22.79%	5,602.29
Aa Aaa	3,335.0	+19.68%	3,991.33
Aaaaaaaaa Aaaa	375.20	+19.43%	448.10

Name	Last	Upside	Fair Value
Aaaaaaaaa A A	1,425.50	+44.37%	2,057.99
Aaaaaaaa Aaaaaaaaaa	356.20	+38.05%	491.73
Aaaaaaaaaaaaaaaa	10,436.0	+25.20%	13,065.87
A Aa Aa Aaaaaaa	158.60	+24.21%	197.00
Aaaaaaaa	4,562.5	+22.79%	5,602.29
Aa Aaa	3,335.0	+19.68%	3,991.33
Aaaaaaaaa Aaaa	375.20	+19.43%	448.10

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Sanofi SA (SASY)

Sanofi (SASY) Income Statement & Profits

Trending Stocks